Search results for "inope"

showing 10 items of 181 documents

Leucine Aminopeptidase Activity in Mast Cells

1959

DURING investigations of the behaviour of leucine aminopeptidase activity of blood-serum in patients with dermatoses and tumours1–3, in a case of diffuse skin mastocytosis of a new-born, we detected heightened activity of leucine aminopeptidase. After mechanical friction of the affected skin, greater activity of leucine aminopeptidase occurred. From this we supposed a release of leucine aminopeptidase from the mast cell infiltrates of the skin. As is well known, in urticaria pigmentosa mechanical irritation of the skin lesions give rise to a degranulation of mast cells4,5 with liberation of histamine and serotonin. Indeed, there is no doubt that mast cells contain the enzyme leucine aminope…

MultidisciplinaryBiochemical PhenomenaHydrolasesChemistryDegranulationConnective tissueMast cellmedicine.diseaseMolecular biologyAminopeptidaseLeucyl Aminopeptidasechemistry.chemical_compoundmedicine.anatomical_structureBiochemistryLeucineEndopeptidasesmedicineHumansUrticaria pigmentosaLiberationMast CellsLeucineHistaminePeptide HydrolasesNature
researchProduct

Insights fromsodium into the impacts of elevated pCO2 and temperature on bivalve shell formation

2017

Ocean acidification and warming are predicted to affect the ability of marine bivalves to build their shells, but little is known about the underlying mechanisms. Shell formation is an extremely complex process requiring a detailed understanding of biomineralization processes. Sodium incorporation into the shells would increase if bivalves rely on the exchange of Na+/H+ to maintain homeostasis for shell formation, thereby shedding new light on the acid-base and ionic regulation at the calcifying front. Here, we investigated the combined effects of seawater pH (8.1, 7.7 and 7.4) and temperature (16 and 22 °C) on the growth and sodium composition of the shells of the blue mussel, Mytilus edul…

Ocean Acidification International Coordination Centre (OA-ICC)Registration number of speciesSalinityTemperateMytilus edulisinorganicAlkalinityGrowth rate standard deviationSodium/Calcium ratioExperimentPatinopecten yessoensisTemperature waterCarbon inorganic dissolvedCalculated using seacarb after Nisumaa et al 2010Aragonite saturation stateNorth PacificAlkalinity totalSalinity standard errortotalSodium Calcium ratiopHTemperaturePartial pressure of carbon dioxide (water) at sea surface temperature (wet air) standard errordissolvedCarbonate ionLaboratory experimentPartial pressure of carbon dioxide (water) at sea surface temperature (wet air)standard errorContainers and aquaria 20 1000 L or 1 m 2Earth System ResearchContainers and aquaria (20-1000 L or &lt; 1 m**2)standard deviationUniform resource locator link to referenceCalcification/DissolutionPotentiometric titrationCalcite saturation statewaterGrowth MorphologyContainers and aquaria (20-1000 L or < 1 m**2)Alkalinity total standard errorBenthosUniform resource locator/link to referenceOcean Acidification International Coordination Centre OA ICCAnimaliaBicarbonate ionTypeTemperature water standard errorCalculated using seacarb after Nisumaa et al. (2010)SpeciespH standard errorGrowth rateCalculated using CO2SYSEvent labelCarbonate system computation flagFugacity of carbon dioxide (water) at sea surface temperature (wet air)CarbonTreatmentPartial pressure of carbon dioxide water at sea surface temperature wet airCarbon dioxideMolluscaGrowth/MorphologySingle speciesCalcification DissolutionBenthic animalsFugacity of carbon dioxide water at sea surface temperature wet airCoast and continental shelf
researchProduct

Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study

2011

Abstract Background and purpose Fludarabine is an adenine nucleoside analogue that has significant activity in hematological malignancies and has shown promising activity in combination with radiation in preclinical solid tumor models. We designed a phase I trial exploring concurrent fludarabine and radiotherapy in patients with advanced non-small cell lung cancer (NSCLC) to determine the maximum tolerated dose (MTD) of fludarabine given with concurrent irradiation. Materials and methods Thirteen patients with stage IIIB NSCLC received thoracic irradiation of 60 Gy. Fludarabine was administered during the 5th and 6th week of radiotherapy. Doses started at 10 mg/m2 per day and increased by s…

Oncologymedicine.medical_specialtyCancer ResearchRadiation-Sensitizing AgentsLung Neoplasmsmedicine.medical_treatmentAntineoplastic AgentsNSCLCMedicine & Public Health; Hematology; Oncology; Internal Medicine; Cancer Research03 medical and health sciencesFludarabine0302 clinical medicineInternal medicineCarcinoma Non-Small-Cell LungCarcinomaMedicineCombined Modality TherapyHumansConcurrent fludarabine and radiotherapy030304 developmental biologyNeoplasm Staging0303 health sciencesOriginal PaperHematologyNucleoside analoguebusiness.industryRadiotherapy DosageGeneral MedicineAdenine nucleosideRadiochemotherapy in stage III NSCLC locally advanced inoperable NSCLCNucleoside analoguemedicine.diseaseCombined Modality Therapy3. Good healthFludarabinerespiratory tract diseasesClinical trialRadiation therapyOncology030220 oncology & carcinogenesisRadiotherapy phase I studybusinessFludarabine; NSCLC; Nucleoside analogue; Concurrent fludarabine and radiotherapy; Radiotherapy phase I study; Radiochemotherapy in stage III NSCLC locally advanced inoperable NSCLCVidarabinemedicine.drug
researchProduct

Late infantile neuronal ceroid lipofuscinosis: Quantitative description of the clinical course in patients withCLN2 mutations

2002

We examined 26 individuals with clinical and electron microscopic signs of late infantile neuronal ceroid lipofuscinosis (LINCL). In 22 cases, we found both pathogenic alleles. Sixteen patients exclusively carried either one or a combination of the two common mutations R208X and IVS5-1G > C. In the remaining cases, four missense mutations could be detected, of which R127Q, N286S, and T353P represent novel, previously not described alleles. A clinical performance score was developed by rating motor, visual, and verbal functions and the incidence of cerebral seizures in 3-month intervals during the course of the disease. A Total Disability Score was derived by summing up the single scores for…

Pediatricsmedicine.medical_specialtyDNA Mutational AnalysisCerliponase alfaDiseaseNeurological disorderAminopeptidasesSeverity of Illness IndexNeuronal Ceroid-LipofuscinosesSeizuresEndopeptidasesSeverity of illnessmedicineMissense mutationDipeptidyl-Peptidases and Tripeptidyl-PeptidasesVision OcularGenetics (clinical)Tripeptidyl-Peptidase 1business.industryDNAmedicine.diseaseTripeptidyl peptidase INeuronal Ceroid Lipofuscinosis Type 2MutationNeuronal ceroid lipofuscinosisSerine ProteasesbusinessPsychomotor PerformancePeptide HydrolasesAmerican Journal of Medical Genetics
researchProduct

Differentiation of Penicillium griseofulvum Dierckx isolates by enzyme assays and by patulin and griseofulvin analyses

1990

The production of patulin and griseofulvin by 49 different isolates of Penicillium griseofulvum Dierckx was analyzed by high-performance liquid chromatography. Eleven isolates were obtained from pistachio nuts, 37 were obtained from wheat seeds, and 1 was obtained from the American Type Culture Collection. Activities of 19 enzymes were also assayed by the API ZYM system. From these results it may be deduced that there are two different groups among the strains tested which cannot be distinguished by morphological and cultural characteristics. One group of isolates did not produce detectable amounts of patulin and griseofulvin when grown in sucrose-yeast extract and Wickerham media, while en…

Penicillium griseofulvumHydrolasesApplied Microbiology and BiotechnologyGriseofulvinPatulinLeucyl Aminopeptidasechemistry.chemical_compoundMycotoxinChromatography High Pressure LiquidEcologybiologybeta-GlucosidasePenicilliumPhosphoamidaseFungi imperfectibiology.organism_classificationGriseofulvinEnzyme assayCulture MediaPatulinchemistryBiochemistryPenicilliumbiology.proteinResearch ArticleFood ScienceBiotechnologyApplied and Environmental Microbiology
researchProduct

Serologisch-hämatologische und immunologische Untersuchungen an winterschlafenden Fledermäusen (Myotis myotis S.)

1963

Antibody deficiency in hibernating bats (Myotis myotis S.) was shown by precipitin reaction. Theγ-globulins in serum of hibernating bats decreased to one half of the normal value. There is significant leukopenia, lymphopenia and eosinopenia. Injected bovine albumin was completely removed within 9 days in active animals, in torpid animals only 1/25 was absorbed from the 6th to the 23rd day.

PharmacologyHibernationmedicine.medical_specialtyLeukopeniaSerum albuminGamma globulinCell BiologyMyotis myotisBiologyPrecipitinmedicine.diseasebiology.organism_classificationSerologyCellular and Molecular NeuroscienceEndocrinologyInternal medicinemedicinebiology.proteinMolecular MedicineEosinopeniamedicine.symptomMolecular BiologyExperientia
researchProduct

Stereoselective synthesis of 1-aminoalkanephosphonic acids with two chiral centers and their activity towards leucine aminopeptidase

2003

The stereoselective synthesis of 1-amino-2-alkylalkanephosphonic acids, namely, compounds bearing two chiral centers, was achieved by the condensation of hypophosphorous acid salts of (R)(+) or (S)(-)-N-alpha-methylbenzylamine with the appropriate aldehydes in isopropanol. Simultaneous deprotection and oxidation by the action of bromine water provided equimolar mixtures of the RS:RR and SR:SS diastereomers of desired acids. They appeared to act as moderate inhibitors of kidney leucine aminopeptidase with potency dependent on the absolute configuration of both centers of chirality.

PharmacologyHypophosphorous acidChemistryStereochemistryOrganic ChemistryOrganophosphonatesDiastereomerAbsolute configurationMetalloendopeptidasesStereoisomerismStereoisomerismAminopeptidaseCatalysisAnalytical Chemistry2-PropanolLeucyl AminopeptidaseZincchemistry.chemical_compoundModels ChemicalDrug DiscoveryStereoselectivityLeucineChirality (chemistry)SpectroscopyChirality
researchProduct

A phosphonamidate containing aromatic N-terminal amino group as inhibitor of leucine aminopeptidase-design, synthesis and stability.

2006

Fully deprotected phosphonamidate dipeptides, predicted as effective inhibitors of cytosolic leucine aminopeptidase, showed unexpected instability in water solution at pH below 12. Their hydrolysis rate was strictly correlated with basicity of the N-terminal amino group. To improve this feature a phosphonamidate analogue containing less basic, aromatic 2-aminophenylphosphonate residue in P1 position of the inhibitor was designed. The target compound was synthesised starting from diethyl 2-nitrophosphonate in several step procedure. The decrease in basicity of the terminal amino moiety of the modified analogue in fact resulted in satisfactory improvement of hydrolytic stability of the P–N bo…

PharmacologyModels MolecularMagnetic Resonance SpectroscopyChemistryStereochemistryphosphonamidateLAP inhibitorsOrganic ChemistryGeneral MedicineAminopeptidaseChemical synthesisResidue (chemistry)HydrolysisLeucyl AminopeptidaseOrganophosphorus CompoundsDrug StabilityDrug DesignDrug Discoveryhydrolytic stabilityMoietyChemical stabilityProtease InhibitorsLeucineLeucyl aminopeptidaseEuropean journal of medicinal chemistry
researchProduct

A structural insight into the P1 S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases

2016

Abstract N′-substituted 1,2-diaminoethylphosphonic acids and 1,2-diaminoethylphosphinic dipeptides were explored to unveil the structural context of the unexpected selectivity of these inhibitors of M1 alanine aminopeptidases (APNs) versus M17 leucine aminopeptidase (LAP). The diaminophosphonic acids were obtained via aziridines in an improved synthetic procedure that was further expanded for the phosphinic pseudodipeptide system. The inhibitory activity, measured for three M1 and one M17 metalloaminopeptidases of different sources (bacterial, human and porcine), revealed several potent compounds (e.g., K i  = 65 nM of 1u for Hs APN). Two structures of an M1 representative (APN from Neisser…

Phosphorous AcidsSwineStereochemistryNeisseria meningitidisCD13 AntigensCrystallography X-RayLigands010402 general chemistry01 natural sciencesAminopeptidaseArticleAminopeptidase NPhosphonic and phosphinic acidsLeucyl AminopeptidaseStructure-Activity RelationshipS1 binding modeDrug DiscoveryAnimalsHumansProtease InhibitorsPharmacologyAlanineBinding Sitesbiology010405 organic chemistryChemistryAminopeptidase NOrganic ChemistryActive siteStructural contextAPN-inhibitor complex structuresDipeptidesGeneral MedicinePhosphinic Acids0104 chemical sciencesMetalloaminopeptidasesPhosphinic Acidsbiology.proteinLeucineSelectivityEuropean Journal of Medicinal Chemistry
researchProduct

l-Tyrosine β-naphthylamide is a potent competitive inhibitor of tyramine N-(hydroxycinnamoyl)transferase in vitro

2001

L-Tyrosine beta-naphthylamide, a synthetic substrate designed to measure tyrosine aminopeptidase activity, is a potent inhibitor of hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl)transferase (THT) purified from elicited tobacco cell-suspension cultures. The inhibition is competitive, with the inhibitor binding reversibly to the tyramine binding site of the enzyme. Similar results were obtained with THT extracted from elicited potato cell-suspension cultures. Ki values were found to be 0.66 microM for the enzyme from tobacco and 0.3 microM for the enzyme from potato. L-Tyrosine 7-amido-4-methylcoumarin, a fluorogenic substrate for tyrosine aminopeptidases, the structure of which is close …

Plant ScienceNaphthalenesHorticultureBiologyBinding CompetitiveBiochemistryAminopeptidaseStructure-Activity Relationshipchemistry.chemical_compoundNon-competitive inhibitionTyrosine aminotransferaseTobaccoTransferaseEnzyme InhibitorsTyrosineMolecular BiologySolanum tuberosumchemistry.chemical_classificationGeneral MedicineTyramineKineticsPlants ToxicEnzymechemistryBiochemistryEnzyme inhibitorbiology.proteinTyrosineAcyltransferasesPhytochemistry
researchProduct